Dr. Öğr. Üyesi ÖZGE HÜRDOĞAN MİRİOĞLU

ATLAS Yayın Analitiği

Makaleler 44

1. Case Report: Familial Mediterranean Fever Complicated by C3 Glomerulonephritis

Velibeyoğlu M., Hürdoğan Ö., Özlük M. Y., UĞURLU S.

International Journal of Rheumatic Diseases , cilt.29, sa.9, 2026 (SCI-Expanded, Scopus)

2. Epithelioid trophoblastic tumour arising in a testicular teratoma: an extremely rare diagnostic pitfall in a male patient

Askin R. R., Hurdogan O., Ozluk Y.

VIRCHOWS ARCHIV , cilt.489, 2026 (SCI-Expanded, Scopus)

3. CD163: a potential biomarker for lupus nephritis activity

Gürel E., Çinar S., Hürdoğan Mirioğlu Ö., Özlük M. Y., Kemeç Türkmen G., Uludağ Ö., et al.

LUPUS SCIENCE & MEDICINE , cilt.13, sa.2, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Histopathological Spectrum of Postchemotherapy Retroperitoneal Lymph Node Dissection in Testicular Cancer: The Impact of Sampling Adequacy and Viable Nonteratomatous Germ Cell Tumor

Hürdoğan Ö., Cantürk Z., Ugar M., Erdem S., Şanlı M. Ö., Ekenel M., et al.

Cerrahpaşa Medical Journal , cilt.50, 2026 (TRDizin) Sürdürülebilir Kalkınma

5. Diagnostic Utility of PRAME and H3K27me3 in Distinguishing Malignant Melanoma From Proliferative Nodules on Congenital Melanocytic Nevi

Hurdogan O., Baykal C., Yilmaz İ., Erdem B. Y., Buyukbabani N., Sari S. O.

Journal of Cutaneous Pathology , cilt.53, sa.8, ss.749-755, 2026 (SCI-Expanded, Scopus)

6. Clinicopathologic features and outcomes of patients with DNAJB9-positive fibrillary glomerulonephritis

Hurdogan Ö., Mirioglu Ş., Cebeci E., Dirim A. B., Bagbudar S., Karaoglan C. S., et al.

CLINICAL KIDNEY JOURNAL , cilt.19, sa.5, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Thrombotic microangiopathy after kidney transplantation: diagnosis and management strategies

Mirioglu Ş., Morelle J., Efe O., Hurdogan Ö., Dirim A. B., Kumru G., et al.

CLINICAL KIDNEY JOURNAL , cilt.19, sa.3, 2026 (SCI-Expanded, Scopus)

8. Hyperbaric oxygen therapy in a rat model of cyclophosphamide-induced hemorrhagic cystitis

Makar C. C., ŞANLI E., Koral G., Hurdogan Ö., Gumus A. V., GÜNVER M. G., et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.58, sa.2, ss.459-466, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. CLINICOPATHOLOGICAL FACTORS INFLUENCING SURVIVAL IN RENAL MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA: A SINGLE CENTER EXPERIENCE FOR 18 YEARS

HÜRDOĞAN Ö., Keles M., ATEŞ Y., Karatay H., ERDEM S., ŞANLI M. Ö., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.89, sa.1, ss.16-22, 2026 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

10. NELL-1-Positive Membranous Nephropathy Following Inhalational Mercury Exposure

Tahillioglu Y., Hurdogan Ö., DİRİM A. B., ARTAN A. S., Celik A., Cebeci E., et al.

KIDNEY INTERNATIONAL REPORTS , cilt.10, sa.12, ss.4306-4307, 2025 (SCI-Expanded, Scopus)

11. Apolipoprotein E Immunostaining Has Diagnostic Utility in Differentiating Dense Deposit Disease and C3 Glomerulonephritis: Clone-Based Evaluation of D719N, EP1373Y, and 1B2C9

Hurdogan Ö., Mirioglu Ş., Dirim A. B., Doksan M., Yildirim Z. N., Turkmen A., et al.

MODERN PATHOLOGY , cilt.38, sa.12, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Beyond the first pregnancy: learning from the history of a kidney transplant recipient who experienced five pregnancies

Artan A. S., Dirim A. B., Mirioğlu Ş., Hürdoğan Ö., Doksan M., Yazıcı H., et al.

JOURNAL OF NEPHROLOGY , cilt.38, sa.9, ss.3037-3040, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. How is the efficacy of patient selection criteria of KEYNOTE 564 for adjuvant pembrolizumab after curative surgical treatment of clear cell renal cell carcinoma with intermediate to high risk of recurrence? A real-life data analysis from single institutional experience

ERDEM S., Tantekin A., Ozervarli F., ERGÜL R. B., Pazir Y., HÜRDOĞAN Ö., et al.

ANNALS OF ONCOLOGY , cilt.36, 2025 (SCI-Expanded, Scopus)

14. C-terminal TREX1 c.914A>G variant in a patient with IgA nephropathy and thrombotic microangiopathy: expanding the clinical and genetic spectrum of IgA nephropathy with microangiopathic lesions

Dirim A. B., Gulec E. Y., Hurdogan Ö., Ozluk Y., Mirioglu Ş., Artan A. S., et al.

CLINICAL KIDNEY JOURNAL , cilt.18, sa.7, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Prediction of Recurrence and Graft Outcomes in Kidney Transplant Recipients with IgA Nephropathy: Role of Genetic and Oxidative Stress Markers

DİRİM A. B., Mirioglu Ş., OTO Ö. A., ARTAN A. S., ÖZLÜK M. Y., Hurdogan Ö., et al.

TURKISH JOURNAL OF NEPHROLOGY , cilt.34, sa.2, 2025 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

16. NELL-1-Associated Membranous Nephropathy Induced by Long-Term Penicillamine Treatment in a Patient With Wilson's Disease

DİRİM A. B., Hurdogan Ö., OTO Ö. A., ARTAN A. S., Suleymanova V., Demir K., et al.

KIDNEY INTERNATIONAL REPORTS , cilt.10, sa.2, ss.614-615, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Challenges in developing a digital pathology consultation network: insights from the MELCAYA experience

Di Gangi D., Gugliotta R., Ugolini F., Szumera-Cieckiewicz A., Alos L., Castrejon N., et al.

EJC SKIN CANCER , cilt.3, 2025 (ESCI, Scopus) Sürdürülebilir Kalkınma

18. Baseline systemic inflammatory indices and clinicopathological features to predict the outcome of acute tubulointerstitial nephritis

Dirim A. B., Namazova N., Dirim M. G., Oto Ö. A., Artan A. S., Hurdogan Ö., et al.

WIENER KLINISCHE WOCHENSCHRIFT , cilt.137, sa.1-2, ss.31-40, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. A Rare Case of Non-Hodgkin Lymphoma Presenting as a Penile Mass

Sevinç A. H., Teke İ., Hürdoğan Ö., Altay A. Y., Cantürk Z., Dursun M., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.42, sa.2, ss.153-155, 2025 (SCI-Expanded, Scopus, TRDizin)

20. Clinicopathological features for the prediction of immunosuppressive treatment responses in sarcoidosis-related kidney involvement: a single-center retrospective study.

DİRİM A. B., Süleymanova V., Hürdoğan Ö., OTO Ö. A., ARTAN A. S., Öztürk S., et al.

Turkish journal of medical sciences , cilt.54, sa.6, ss.1252-1264, 2024 (SCI-Expanded, Scopus, TRDizin)

21. AA Amyloidosis: A Contemporary View

Mirioglu Ş., Uludag O., Hurdogan Ö., KUMRU G., Berke I., Doumas S. A., et al.

CURRENT RHEUMATOLOGY REPORTS , cilt.26, sa.7, ss.248-259, 2024 (SCI-Expanded, Scopus)

22. LIM Zinc Finger Domain Containing 1 Risk Genotype of Recipient Is Associated with Renal Tubular Inflammation in Kidney Transplantation

Caliskan Y., Ozluk Y., Kurashima K., Mirioglu Ş., Dirim A. B., Hurdogan Ö., et al.

GENES , cilt.15, sa.6, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. The role of [⁶⁸ Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study

CİVAN C., Kuyumcu S., Has Simsek D., Sanli O., Isik E. G., Ozkan Z. G., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.51, sa.3, ss.852-861, 2024 (SCI-Expanded, Scopus)

24. Anti-Glomerular Basement Membrane Disease in a Pediatric Patient with SARS-CoV-2 Infection: A Case Report

AKSU B., KÜÇÜK N., YÜRÜK YILDIRIM Z. N., ÖZLÜK M. Y., HÜRDOĞAN Ö., YILMAZ A.

Çocuk Dergisi , cilt.23, 2024 (TRDizin)

25. Primary Classic Penile Kaposi’s Sarcoma in a Middle Age Circumcised HIV-Negative Patient: Presentation of an Unusual Case

ERGÜL R. B., ORTAÇ M., TONYALI Ş., PEHLİVAN G., ÖZTÜRK SARI Ş., HÜRDOĞAN Ö., et al.

MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL , cilt.58, sa.2, ss.241-243, 2024 (ESCI, TRDizin)

26. Diagnostic yield and safety of percutaneous native kidney biopsy in pregnancy: 20-years of single-center experience.

Yazici H., Dirim A. B., Garayeva N., Safak S., Ozluk Y., Hurdogan Ö., et al.

Journal of nephrology , cilt.36, sa.9, ss.2507-2517, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Two cases of IgA nephropathy after splenectomy: spleen as a silent culprit in the pathogenesis of IgA nephropathy.

Dirim A. B., Agargun B. F., Hurdogan Ö., Ozluk Y., Safak S., Garayeva N., et al.

Journal of nephrology , cilt.36, sa.8, ss.2381-2385, 2023 (SCI-Expanded, Scopus)

28. Spatial Distribution of Macrophage Subtypes Among Rejection Subtypes in Renal Transplant Biopsies by Dual Immunohistochemistry

Hurdogan Ö., Karakus F., Dirim A. B., Aksu B., Saygili S., Turkmen A., et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , cilt.31, sa.4, ss.224-231, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Heme oxygenase-1 deficiency as an extremely rare cause of AA-type renal amyloidosis: Expanding the clinical features and review of the literature.

Dirim A. B., Kalayci T., Safak S., Garayeva N., Gultekin B., Hurdogan Ö., et al.

Clinical rheumatology , cilt.42, sa.2, ss.597-606, 2023 (SCI-Expanded, Scopus)

30. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 Mutation Profile and Histomorphological Analysis of Anorectal Melanomas: A Clinicopathologic Study.

Taskin O. C., Sari Ş., Yilmaz I., Hurdogan Ö., Keskin M., Buyukbabani N., et al.

Turk patoloji dergisi , cilt.39, ss.23-30, 2023 (ESCI, Scopus, TRDizin)

31. Digital Quantification of Intratumoral CD8+ T-Cells Predicts Relapse and Unfavorable Outcome in Uveal Melanoma

Hurdogan O., De Logu F., Galli F., Tuncer S., Ugolini F., Simi S., et al.

Cancers , cilt.14, sa.23, 2022 (SCI-Expanded, Scopus)

32. Secondary Localized Cutaneous Amyloidosis is not Rare in Bowen's Disease and Bowenoid Papulosis.

Baykal C., Hurdogan Ö., Kobaner G. B., Ekinci A. P., Buyukbabani N.

Turk patoloji dergisi , cilt.38, ss.54-59, 2022 (ESCI, Scopus, TRDizin)

33. The role of FOXL2, SOX9, and beta-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary

Onder S., Hurdogan O., Bayram A., Yilmaz I., Sozen H., Yavuz E.

VIRCHOWS ARCHIV , cilt.479, sa.2, ss.317-324, 2021 (SCI-Expanded, Scopus)

34. DICER1 Hotspot Mutations in Pleuropulmonary Blastoma: A Case Series From a Tertiary Center

Hurdogan O., YILMAZ İ., Bay S. B., VURAL S., Tugcu D., Kebudi R., et al.

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY , cilt.23, sa.3, ss.204-209, 2020 (SCI-Expanded, Scopus)

35. EGFR mutation analysis in lung adenocarcinoma in cerebrospinal fluid and peripheral blood: a case presentation

Hurdogan O., Sari M., Yilmazbayhan D., Ozluk Y.

VIRCHOWS ARCHIV , cilt.475, 2019 (SCI-Expanded, Scopus)

36. Mucinous tubular and spindle cell carcinoma: a report of 8 cases from a tertiary center

Hurdogan O., Karatay H., Erdem S., Kilicaslan I., Ozluk Y.

VIRCHOWS ARCHIV , cilt.475, 2019 (SCI-Expanded, Scopus)

37. Squamous cell carcinoma metastasis in pleural and pericardial effusions

Sunnetcioglu E., Aydin C., Hurdogan O., Yilmazbayhan D., Firat P., Ozluk Y.

VIRCHOWS ARCHIV , cilt.475, 2019 (SCI-Expanded, Scopus)

38. Cystic Anastomosing Hemangioma of the Ovary: A Case Report With Immunohistochemical and Ultrastructural Analysis

Gunduz M., Hurdogan O., Onder S., Yavuz E.

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY , cilt.27, sa.4, ss.437-440, 2019 (SCI-Expanded, Scopus)

39. A case report demonstrating potential utility of topical imiquimod for cutaneous Rosai-Dorfman disease.

KARADAG A., TEKIN B., Hurdogan O., DAGDELEN D., Dogan O., Buyukbabani N.

Dermatologic therapy , cilt.32, 2019 (SCI-Expanded, Scopus)

40. Gastrointestinal large B-cell lymphoma with IRF4 rearrangement - a case report

Hurdogan O., Yegen G., Arslantas E., Gulluoglu M., Dogan I. O.

VIRCHOWS ARCHIV , cilt.473, 2018 (SCI-Expanded, Scopus)

41. Pleuropulmonary blastoma: A case series from a Tertiary Center

Hurdogan O., Ozluk Y., Bay S., Vural S., Kebudi R., Gun F., et al.

VIRCHOWS ARCHIV , cilt.471, 2017 (SCI-Expanded, Scopus)

42. Ectodermal dysplasia-skin fragility syndrome resulting from a new atypical homozygous cryptic acceptor splice site mutation in PKP1

Hsu C., Liu L., Can P. K., Kocaturk E., McMillan J. R., Gungor S., et al.

JOURNAL OF DERMATOLOGICAL SCIENCE , cilt.84, sa.2, ss.210-212, 2016 (SCI-Expanded, Scopus)

43. Two cases of primary stabbing headache

Guntel M., Hurdogan Ö., Uluduz D., Duman T.

AGRI-THE JOURNAL OF THE TURKISH SOCIETY OF ALGOLOGY , cilt.28, sa.2, ss.106-108, 2016 (ESCI, Scopus, TRDizin)

44. Diffuse large B-cell lymphoma and multifocal ischemic stroke

Ince B., Eskazan E., Hurdogan O., Koseoglu L., Ferhanoglu B.

CEREBROVASCULAR DISEASES , cilt.37, ss.600, 2014 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 31

1. Primer glomerüler hastalığı olan hastalarda tekrarlanan nativ böbrek biyopsilerinin tanı, tedavi ve prognozdaki rolü: tek merkezli retrospektif bir çalışma

Seyrek F., Dirim A. B., Oto Ö. A., Artan A. S., Mirioğlu Ş., Hürdoğan Ö., et al.

42. Ulusal Nefroloji Kongresi, Antalya, Türkiye, 12 - 16 Kasım 2025, ss.36, (Özet Bildiri)

2. How is the efficacy of patient selection criteria for adjuvant pembrolizumab after curative surgery of clear cell renal cell carcinoma with intermediate to high risk of recurrence? A real-life data analysis from single institutional experience

Erdem S., Tantekin S. A., Özervarlı M. F., Pazır Y., Hürdoğan Ö., Özlük M. Y., et al.

IURES 2025 Kongresi, Muğla, Türkiye, 6 - 09 Kasım 2025, ss.28-30, (Özet Bildiri)

3. How different are the expression levels of immune checkpoint molecules and their roles on the prognosis in clear cell, papillary and chromophobe subtypes of renal cell carcinoma?

Turan S., Erdem S., Campi R., Bex A., Hürdoğan Ö., Özlük M. Y., et al.

IURES 2025 Kongresi, Muğla, Türkiye, 6 - 09 Kasım 2025, ss.22-24, (Özet Bildiri)

4. Clinical and Radiological Mimicry of Renal Malignancy in IgG4-Related Kidney Disease: A Case Report and Comprehensive Literature Review

Ergül R. B., Erdem S., Aydınoğlu A. T., Şanlı M. Ö., Özcan F., Hürdoğan Ö., et al.

IURES 2025 Kongresi, Muğla, Türkiye, 6 - 09 Kasım 2025, ss.40-43, (Özet Bildiri)

5. Investigation of BRCA1, BRCA2, and RAD51 gene expression levels in nonmetastatic prostate cancer patients undergoing radical prostatectomy

Özcan B., Erdem S., Öztan G., Savran Karadeniz M., Özlük M. Y., Hürdoğan Ö., et al.

IURES 2025 Kongresi, Muğla, Türkiye, 6 - 09 Kasım 2025, ss.2-5, (Tam Metin Bildiri)

6. Biphasic squamoid alveolar renal cell carcinoma: a report of three cases with immunohistochemical and FISH analysis

Üzümcü A., Hürdoğan Ö., Ahmed M. A., Kılıçaslan I., Özlük M. Y.

37th European Congress of Pathology, Vienna, Avusturya, 6 - 10 Eylül 2025, cilt.487, ss.536, (Özet Bildiri)

7. Böbrek nakli alıcılarında LIMS1 rs893403 genotiplerinin posttransplant glomerülonefritle ilişkisi

MİRİOĞLU Ş., DİRİM A. B., OTO Ö. A., ARTAN A. S., HÜRDOĞAN Ö., ÖZTÜRK S., et al.

41. Ulusal Nefroloji Kongresi, Antalya, Türkiye, 4 - 08 Aralık 2024, ss.14, (Özet Bildiri)

8. TESTIKÜLER MALIGN MIKST GERM HÜCRELI TÜMÖR OLGUSUNDA RETROPERITONEAL LENF NODU DISEKSIYONUNDA HEPATOID TIPTE YOLK SAK TÜMÖRÜ METASTAZI: OLGU SUNUMU

Sayar E., Hürdoğan Ö., Özlük M. Y., Erdem S., Kılıçaslan I.

33. ulusal patoloji kongresi, Antalya, Türkiye, 12 - 16 Kasım 2024, cilt.8, ss.327, (Özet Bildiri)

9. Ürogenital sistemin metastatik tümörleri: 20 yıllık tek merkez deneyimi

Cantürk Z., Hürdoğan Ö., Kılıçaslan I., Özlük M. Y.

33. Ulusal Patoloji Kongresi, Antalya, Türkiye, 12 - 16 Kasım 2024, cilt.8, ss.91450, (Özet Bildiri)

10. RADIKAL PROSTATEKTOMI MATERYALINDE EŞ ZAMANLI MALAKOPLAKI VE PROSTATIK ADENOKARSINOM: OLGU SUNUMU

Aşkın R. R., Hürdoğan Ö., Şanlı M. Ö., Özlük M. Y.

33. Ulusal Patoloji Kongresi, Antalya, Türkiye, 12 - 16 Kasım 2024, ss.301, (Özet Bildiri)

11. Çocukluk Yaş Grubunda Böbrek Tümörleri: Tek Merkez Deneyimi

Barut N. B., Kılıçaslan I., Hürdoğan Ö., Özlük M. Y.

33. Ulusal Patoloji Kongresi, Antalya, Türkiye, 12 - 16 Kasım 2024, cilt.8, sa.396, (Tam Metin Bildiri)

12. TESTIKÜLER LEYDIG HÜCRELI TÜMÖRLERDE FUMARAT HIDRATAZ EKSPRESYONU

Üzümcü A., Hürdoğan Ö., Kılıçaslan I., Özlük M. Y.

33. Ulusal Patoloji Kongresi, Antalya, Türkiye, 12 - 16 Kasım 2024, cilt.8, ss.325, (Özet Bildiri)

13. How is the efficacy of patient selection criteria for adjuvant pembrolizumab after curative surgical treatment of clear cell renal cell carcinoma with intermediate to high risk of recurrence? A real-life data analysis from single institutional experience

ERDEM S., TANTEKİN S. A., ÖZERVARLI M. F., ERGÜL R. B., PAZIR Y., HÜRDOĞAN Ö., et al.

16th European Multidisciplinary Congress on Urological Cancers (EMUC) 2024, Lizbon, Portekiz, 7 - 10 Kasım 2024, ss.262-263, (Tam Metin Bildiri)

14. How different are the expression levels of immune checkpoint molecules and their roles on the prognosis in clear cell, papillary and chromophobe subtypes of renal cell carcinoma?

TURAN S., ERDEM S., HÜRDOĞAN Ö., ÖZLÜK M. Y., KILIÇASLAN I., ŞANLI M. Ö., et al.

16th European Multidisciplinary Congress on Urological Cancers (EMUC) 2024, Lizbon, Portekiz, 7 - 10 Kasım 2024, ss.213-214, (Tam Metin Bildiri)

15. Siklofosfamid ile indüklenen hemorajik sistit sıçan modelinde hiperbarik oksijen tedavisinin etkinliğinin araştırılması

Makar Ç. C., Şanlı E., Koral G., Hürdoğan Ö., Günver M. G., Gümüş A. V., et al.

17. Ulusal Sualtı Hekimliği ve Hiperbarik Tıp Toplantısı (HİTAM’24), İstanbul, Türkiye, 19 Ekim 2024, ss.113-130, (Tam Metin Bildiri)

16. An interobserver reproducibility study on PD-L1 (SP263) in urothelial carcinoma

Barut N. B., Hürdoğan Ö., Kılıçaslan I., Özlük M. Y.

36th European Congress of Pathology, Florence, İtalya, 7 - 11 Eylül 2024, cilt.485, sa.2701, ss.521, (Özet Bildiri)

17. Nadir bir vaka: Peniste kitle olarak kendini gösteren Non-Hodgkin Lenfoma

Teke İ., Gürcan M., Hürdoğan Ö., Cantürk Z., Dursun M., Kadıoğlu A.

23. Ulusal Androloji Kongresi, Eskişehir, Türkiye, 17 - 19 Mayıs 2024, ss.68-69, (Tam Metin Bildiri)

18. Dirençli Hipoalbuminemi olan IgA Nefropatisi Olgu Sunumu

Ataç Zıba S., NURSAL D., Mahmudova G., HÜRDOĞAN Ö., AKSU B., YÜRÜK YILDIRIM Z. N., et al.

46.Pediatri Günleri ve 25.Pediatri Hemşireliği Günleri, İstanbul, Türkiye, 16 Nisan 2024, (Özet Bildiri)

19. SARS-COV-2 INFECTION AND ANTI-GLOMERULAR BASEMENT DISEASE: A CASE REPORT

Aksu B., Küçük N., Yürük Yıldırım Z. N., Özlük M. Y., Hürdoğan Ö., Yılmaz A.

55th Annual Meeting of the European Society for Paediatric Nephrology, Vilniaus, Litvanya, 28 Eylül - 01 Ekim 2023, ss.329, (Özet Bildiri) Sürdürülebilir Kalkınma